[Pubmed] Neurometabolic and brain functional alterations associated with cognitive impairment in patients with myastheni
Posté : 29 févr. 2024 12:00
Neuroscience. 2024 Feb 27:S0306-4522(24)00085-X. doi: 10.1016/j.neuroscience.2024.02.021. Online ahead of print.
ABSTRACT
Whether patients with myasthenia gravis (MG) exhibit cognitive impairment is controversial. Also the underlying mechanisms are unknown. We aimed to investigate alterations in cognitive function, neurometabolite levels, and brain function in patients with MG and to explore the associations between abnormal regional brain functional activity, neurometabolite concentrations in the MPFC and left thalamus, and cognitive activity in patients with MG. Neuropsychological tests, proton magnetic resonance spectroscopy, and resting-state functional magnetic resonance imaging were performed on 41 patients with MG and 45 race-, sex-, age-, and education-matched healthy controls (HCs). The results suggest that MG is accompanied by cognitive decline, as indicated by global cognitive function, visual-spatial function, language, memory, abnormalities in regional brain functional activity, and neurometabolite alterations (including GABA, NAA, and Cho) in the medial prefrontal cortex (MPFC) and left thalamus. Cognitive impairment in patients with MG may be related to abnormal regional brain functional activity and changes in neurometabolites, and regional brain functional activity may be modulated by specific neurometabolites.
PMID:38423165 | DOI:10.1016/j.neuroscience.2024.02.021
Source: https://pubmed.ncbi.nlm.nih.gov/3842316 ... t9+e462414